Background illustration for clinical trials search

Paid Clinical Trials Indianapolis

Discover 901 paid clinical trials in Indianapolis, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer

for
Epithelial Ovarian Cancer
Location: Indianapolis IN, Blue Ash OH, Dayton OH, Fort Wayne IN,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07218809

Phase 3, Recruiting

Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma

for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Indianapolis IN, Louisville KY, Zion IL, St Louis MO,
Sponsor: Arcus Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07011719

Phase 3, Recruiting

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

for
Asthma
Location: Indianapolis IN, Dayton OH, Louisville KY, Normal IL,
Sponsor: AstraZeneca

Sex: All

Age: 12 - 17

Code: NCT06307665

Phase 3, Recruiting

Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis

for
Severe Hypertriglyceridemia
Location: Indianapolis IN, Springfield IL, Ann Arbor MI,
Sponsor: Arrowhead Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06880770

Phase 3, Recruiting

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

for
Endometrial Cancer, Malignant Solid Tumour
Location: Indianapolis IN, Cincinnati OH, Dayton OH,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07044336

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Indianapolis IN, Cincinnati OH, Lima OH, Versailles KY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Indianapolis IN, Evansville IN, Owensboro KY,
Sponsor: AstraZeneca

Sex: All

Age: 40 - 70+

Code: NCT06878261

Phase 3, Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Indianapolis IN, Richmond IN, Springfield OH,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase 3, Recruiting

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for
Chronic Kidney Disease and Hypertension
Location: Indianapolis IN, Cincinnati OH, Champaign IL,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06742723

Phase 3, Recruiting

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

for
Heart Failure
Location: Indianapolis IN, Richmond IN, Cincinnati OH, Dayton OH,
Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT06677060

Phase 3, Recruiting

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

for
Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer,
Location: Indianapolis IN, Fairfield OH, Cincinnati OH,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222566

Phase 3, Recruiting

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

for
Carcinoma, Non-Small Cell Lung,
Location: Indianapolis IN, Fort Wayne IN, Crown Point IN,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04389632

Phase 1, Recruiting

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

for
Solid Tumours
Location: Indianapolis IN, Maumee OH, Arlington Heights IL,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06581432

Phase 2, Recruiting

Galleri® in the Medicare Population.

for
Cancer
Location: Indianapolis IN, Fishers IN, Anderson IN, Kokomo IN,
Sponsor: GRAIL, Inc.

Sex: All

Age: 50+

Code: NCT05673018

Recruiting

Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

for
Primary Membranous Nephropathy
Location: Indianapolis IN, Hinsdale IL, Wauwatosa WI,
Sponsor: Vertex Pharmaceuticals Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07204275

Phase 2, Phase 3, Recruiting

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

for
Alzheimer Disease, Dementia, Plaque, Amyloid
Location: Indianapolis IN, Lima OH, Chicago IL, Gainesville GA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 55+

Code: NCT07602582

Phase 3, Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Indianapolis IN, Carmel IN, Oak Park IL, Nashville TN,
Sponsor: Apellis Pharmaceuticals, Inc.

Sex: All

Age: 60+

Code: NCT07215390

Phase 2, Recruiting

Locomotor Recovery and Compensation Post-stroke (LRC)

for
Stroke
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18 - 70+

Code: NCT05081713

Recruiting

High vs Low-frequency of High-intensity Training in Chronic Stroke

for
Stroke
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18 - 70+

Code: NCT06612723

Recruiting

ReWalk Personal Device Postmarket Study

for
Injuries, Spinal Cord
Location: Indianapolis IN, Pomona CA, Palo Alto CA
Sponsor: ReWalk Robotics, Inc.

Sex: All

Age: 18+

Code: NCT02944669

Recruiting